National Health Investors, Inc. (NYSE:NHI) Receives $86.67 Average Price Target from Analysts

Shares of National Health Investors, Inc. (NYSE:NHI) have been given an average rating of “Moderate Buy” by the seven research firms that are covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a hold recommendation, four have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month price target among brokerages that have covered the stock in the last year is $86.6667.

Several brokerages have recently issued reports on NHI. National Bank Financial set a $85.00 price target on National Health Investors in a research report on Tuesday, January 20th. Wells Fargo & Company raised their target price on National Health Investors from $80.00 to $85.00 and gave the company an “equal weight” rating in a research note on Tuesday, November 25th. Truist Financial lifted their target price on National Health Investors from $85.00 to $92.00 and gave the stock a “buy” rating in a report on Thursday, March 12th. Deutsche Bank Aktiengesellschaft downgraded shares of National Health Investors from a “buy” rating to a “hold” rating and set a $85.00 price target for the company. in a report on Tuesday, January 20th. Finally, KeyCorp raised their price objective on shares of National Health Investors from $80.00 to $88.00 and gave the company an “overweight” rating in a research report on Thursday, December 4th.

National Health Investors Trading Up 0.6%

Shares of NYSE:NHI opened at $82.33 on Tuesday. The company has a 50 day moving average of $84.29 and a 200-day moving average of $79.68. The company has a current ratio of 6.90, a quick ratio of 6.90 and a debt-to-equity ratio of 0.76. The firm has a market cap of $3.99 billion, a P/E ratio of 27.26, a P/E/G ratio of 4.44 and a beta of 0.65. National Health Investors has a twelve month low of $66.41 and a twelve month high of $91.38.

National Health Investors (NYSE:NHI) last posted its quarterly earnings data on Thursday, February 26th. The real estate investment trust reported $1.22 EPS for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.01). National Health Investors had a net margin of 37.81% and a return on equity of 9.56%. The company had revenue of $105.82 million for the quarter, compared to analyst estimates of $95.12 million. During the same quarter in the prior year, the business earned $1.24 EPS. National Health Investors’s revenue was up 6.8% compared to the same quarter last year. National Health Investors has set its FY 2026 guidance at 4.940-4.990 EPS. As a group, analysts anticipate that National Health Investors will post 4.41 earnings per share for the current fiscal year.

National Health Investors Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 1st. Stockholders of record on Tuesday, March 31st will be paid a dividend of $0.92 per share. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $3.68 annualized dividend and a dividend yield of 4.5%. National Health Investors’s dividend payout ratio (DPR) is currently 121.85%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Renaissance Group LLC boosted its position in National Health Investors by 3.8% during the 4th quarter. Renaissance Group LLC now owns 3,206 shares of the real estate investment trust’s stock worth $245,000 after acquiring an additional 117 shares during the period. GAMMA Investing LLC increased its holdings in shares of National Health Investors by 41.8% in the 4th quarter. GAMMA Investing LLC now owns 461 shares of the real estate investment trust’s stock valued at $35,000 after purchasing an additional 136 shares during the period. Captrust Financial Advisors lifted its position in shares of National Health Investors by 1.7% in the fourth quarter. Captrust Financial Advisors now owns 8,907 shares of the real estate investment trust’s stock worth $680,000 after purchasing an additional 146 shares in the last quarter. Creative Planning boosted its holdings in shares of National Health Investors by 2.2% during the second quarter. Creative Planning now owns 8,217 shares of the real estate investment trust’s stock worth $576,000 after purchasing an additional 177 shares during the period. Finally, PNC Financial Services Group Inc. boosted its holdings in shares of National Health Investors by 5.0% during the third quarter. PNC Financial Services Group Inc. now owns 3,731 shares of the real estate investment trust’s stock worth $297,000 after purchasing an additional 177 shares during the period. 62.51% of the stock is currently owned by institutional investors and hedge funds.

About National Health Investors

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.